LSB(Delisted)
LakeShore BiopharmaยทNASDAQ
--
--(--)
LSB fundamentals
LakeShore Biopharma (LSB) released its earnings on Apr 19, 2024: revenue was -- (YoY 0.00%), beat estimates; EPS was -- (YoY 0.00%), missed estimates.
Revenue / YoY
--
0.00%
EPS / YoY
--
0.00%
Report date
Apr 19, 2024
EPS
Revenue
Revenue & Expenses
LSB has released its 2024 Q4 earnings report, with revenue of 18.75M, reflecting a YoY change of 21.43%, and net profit of -25.09M, showing a YoY change of -112.04%. The Sankey diagram below clearly presents LSB's revenue sources and cost distribution.
Key Indicators
LakeShore Biopharma (LSB) key financial stats and ratios, covering profitability, financial health, and leverage.
LakeShore Biopharma (LSB)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
LakeShore Biopharma (LSB)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
LakeShore Biopharma (LSB)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does LakeShore Biopharma (LSB) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track LakeShore Biopharma (LSB) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
No Data
